International, prospective study of mepolizumab in severe asthma: REALITI-A at 2yrs

被引：1
|
作者：
Caruso, C. [1 ]
Canonica, G. W. [2 ]
Patel, M. [3 ]
Smith, A. [3 ]
Liu, M. C. [4 ]
Alfonso-Cristancho, R. [5 ]
Price, R. G. [6 ]
Jakes, R. W. [7 ]
Demetriou, L. [8 ]
Valero, A. [9 ]
Pilette, C. [10 ]
Howarth, P. [11 ]
机构：
[1] Fdn Policlin Gemelli, IRCCS, UOSD DH Gastroenterol, Rome, Italy
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] Univ Hosp Wishaw, Dept Resp Med, Wishaw, Scotland
[4] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD USA
[5] GSK, Value Evidence & Outcomes, Collegeville, PA USA
[6] GSK, Biostat, Stevenage, Herts, England
[7] GSK, Epidemiol, GSK House, Brentford, England
[8] GSK, Value Evidence & Outcomes, Stevenage, Herts, England
[9] Univ Barcelona, IDIBAPS, CIBER Enfermedades Respiratorias CIBERES, Hosp Clin Barcelona,Secc Alergol,Serv Neumol & Al, Barcelona, Spain
[10] CIBER Enfermedades Resp CIBERES, IDIBAPS, Barcelona, Spain
[11] Clin Univ St Luc, Dept Pulm Med, Brussels, Belgium
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.4589
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
4589
引用
收藏
页数：2
相关论文
共 50 条
  • [1] International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A
    Pilette, Charles
    Canonica, Giorgio Walter
    Chaudhuri, Rekha
    Lee, F. Eun-Hyung
    Lee, Jason Kihyuk
    Sanchez, Carlos Almonacid
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Maxwell, Aoife
    Price, Robert
    Howarth, Peter
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 566 - 566
  • [2] Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis
    Harrison, Tim
    Canonica, Giorgio Walter
    Chupp, Geoffrey
    Lee, Jason
    Schleich, Florence
    Welte, Tobias
    Valero, Antonio
    Gemzoe, Kim
    Maxwell, Aoife
    Joksaite, Sandra
    Yang, Shibing
    Howarth, Peter
    Van Dyke, Melissa K.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (04)
  • [3] Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A
    Pilette, Charles
    Canonica, Giorgio Walter
    Chaudhuri, Rekha
    Lee, F. Eun-Hyung
    Lee, Jason Kihyuk
    Almonacid Sanchez, Carlos
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Maxwell, Aoife
    Price, Robert
    Howarth, Peter
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [4] Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Mepolizumab in Real-Life Settings: The Prospective, REALITI-A Study
    Chaudhuri, R.
    Canonica, G. W.
    Bals, R.
    Lougheed, M. D.
    Pilette, C.
    Ramos-Barbon, D.
    Pollard, S.
    Maxwell, A.
    Worsley, S.
    Van Dyke, M. K.
    Joksaite, S.
    Howarth, P.
    Cristancho, R. Alfonso
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [5] Patient and Physician Perspectives on Mepolizumab Treatment in Severe Asthma: Data From the REALITI-A Study
    Lee, Jason
    Canonica, Giorgio
    Caruso, Cristiano
    Chaudhuri, Rekha
    Pilette, Charles
    Price, Robert
    Howarth, Peter
    Lee, F. Eun-Hyung
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB102 - AB102
  • [6] Mepolizumab in Patients With Severe Asthma and Comorbidities: 1-Year REALITI-A Analysis
    Liu, Mark C.
    Bagnasco, Diego
    Matucci, Andrea
    Pilette, Charles
    Price, Robert G.
    Maxwell, Aoife C.
    Alfonso-Cristancho, Rafael
    Jakes, Rupert W.
    Lee, Jason K.
    Howarth, Peter
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (12): : 3650 - +
  • [7] Real-World Impact of Mepolizumab on the Oral Corticosteroid Freedom Component of Clinical Remission in Severe Eosinophilic Asthma: International, Prospective REALITI-A Study
    Chupp, Geoffrey
    Heaney, Liam
    Price, Rob
    Brusselle, Guy
    Gardiner, Frances
    Raimondi, Alejandro
    Chaudhuri, Rekha
    Howarth, Peter
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB20 - AB20
  • [8] Clinical Remission Achievement in Severe Asthma Following Mepolizumab Treatment: Results From the REALITI-A Study at 2 Years
    Brusselle, G.
    Lougheed, M.
    Canonica, G.
    Munoz-Esquerre, M.
    Heaney, L.
    Price, R.
    Howarth, P.
    Raimondi, A.
    Gardiner, F.
    Chupp, G.
    Welte, T.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [9] REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma
    Pilette, Charles
    Canonica, Giorgio Walter
    Chaudhuri, Rekha
    Chupp, Geoffrey
    Lee, F. Eun-Hyung
    Lee, Jason Kihyuk
    Almonacid, Carlos
    Welte, Tobias
    Alfonso-Cristancho, Rafael
    Jakes, Rupert W.
    Maxwell, Aoife
    Price, Robert G.
    Howarth, Peter
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (10): : 2646 - 2656
  • [10] Real-world outcomes with mepolizumab in patients with severe asthma and comorbid anxiety/depression: REALITI-A at 2 years
    Chaudhuri, Rekha
    Liu, Mark C.
    Bagnasco, Diego
    Matucci, Andrea
    Pilette, Charles
    Price, Robert G.
    Demetriou, Lydia
    Howarth, Peter
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
12345